We are live on ! Find out more
ALIM

Alimera Sciences
ALIM

Delisted

ALIM was delisted on the 13th of September, 2024.

Back to rankings

39 hedge funds and large institutions have $25.6M invested in Alimera Sciences in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

9% less funds holding

Funds holding: 43 → 39 (-4)

29% less capital invested

Capital invested by funds: $35.9M → $25.6M (-$10.3M)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
39
Holders Change
-4
Holders Change %
-9.3%
% of All Funds
0.87%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
8
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RA
Royce & Associates
New York
+$117K
2
Renaissance Technologies
Renaissance Technologies
New York
+$74.9K
3
DMK
David M. Knott
+$63.1K
4
VF
Virtu Financial
New York
+$30.2K
5
BRWM
B. Riley Wealth Management
Tennessee
+$18.9K

Top Sellers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
-$428K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$396K
3
ACP
Acuta Capital Partners
California
-$262K
4
TSS
Two Sigma Securities
New York
-$26K
5
BRF
B. Riley Financial
California
-$24.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Invesco
26
Invesco
Georgia
$11K +$1.62K +111 +12%
Wells Fargo
27
Wells Fargo
California
$10K – – –
SCM
28
Southport Capital Management
Tennessee
$8K -$17K -1,164 -61%
SWM
29
SeaCrest Wealth Management
New York
$7K – – –
SRC
30
Shufro Rose & Co
New York
$7K – – –
SIAG
31
Signet Investment Advisory Group
Rhode Island
$5K +$7.29K +500 New
UBS Group
32
UBS Group
Switzerland
$2K +$802 +55 +31%
PCM
33
Prelude Capital Management
New York
$1K -$15 -1 -1%
LTFS
34
Ladenburg Thalmann Financial Services
Florida
$1K – – –
S
35
SignatureFD
Georgia
$1K – – –
BNP Paribas Financial Markets
36
BNP Paribas Financial Markets
France
$4 – – –
ACP
37
Acuta Capital Partners
California
– -$262K -17,833 Closed
TSS
38
Two Sigma Securities
New York
– -$26K -1,767 Closed
Millennium Management
39
Millennium Management
New York
– -$17K -1,170 Closed
Goldman Sachs
40
Goldman Sachs
New York
– -$12K -828 Closed
Jane Street
41
Jane Street
New York
– -$11K -769 Closed
CFGS
42
Concourse Financial Group Securities
Alabama
– +$976 +67 New
1
2

ALIM Hedge Fund Activity: Q4 2018 in Review

39 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q4 2018, worth a combined $25.6M — down 29% from $35.9M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ALIM and 3 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 8 added.

The largest buyer was Royce & Associates, adding an estimated $117K. The largest seller was Stonepine Capital Management, cutting an estimated $428K.

  • 39 institutional investors held Alimera Sciences (ALIM) as of Q4 2018, down from 43 in Q3 2018.
  • Funds reported $25.6M of Alimera Sciences stock for Q4 2018, down 29% quarter-over-quarter.
  • 3 funds opened new Alimera Sciences positions in Q4 2018 and 6 closed out, a net change of -3 holders.
  • The largest Alimera Sciences buyer in Q4 2018 was Royce & Associates, an estimated $117K added.
  • The largest Alimera Sciences seller in Q4 2018 was Stonepine Capital Management, an estimated $428K sold.

Based on aggregated 13F filings for Q4 2018.